United Therapeutics Corporation (UTHR)

NASDAQ
217.10
-3.31(-1.50%)
Pre Market
219.20
+2.10(+0.97%)
- Real-time Data
  • Volume:
    554,141
  • Day's Range:
    215.41 - 224.06
  • 52 wk Range:
    158.38 - 245.48

UTHR Overview

Prev. Close
220.41
Day's Range
215.41-224.06
Revenue
1.79B
Open
220.66
52 wk Range
158.38-245.48
EPS
13.96
Volume
554,141
Market Cap
9.88B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
485,898
P/E Ratio
16.78
Beta
0.534
1-Year Change
7.15%
Shares Outstanding
45,516,299
Next Earnings Date
02 Nov 2022
What is your sentiment on United Therapeutics?
or
Market is currently closed. Voting is open during market hours.

United Therapeutics Corporation News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

United Therapeutics Corporation Analysis

United Therapeutics Corporation Company Profile

United Therapeutics Corporation Company Profile

Employees
965

United Therapeutics Corporation is a pharmaceutical company. The Company markets and sells four commercial therapies in the United States to treat ulmonary arterial hypertension (PAH): Tyvaso (treprostinil) Inhalation Solution (Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). Tyvaso has also been approved to treat pulmonary hypertension associated with interstitial lung disease. It also markets and sells an oncology product, Unituxin (dinutuximab) Injection (Unituxin), which is approved for the treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin (Remunity). It also includes technologies designed supply of transplantable organs and tissues and improves outcomes for transplant recipients through regenerative medicine, three-dimensional (3-D) organ bioprinting, xenotransplantation and ex-vivo lung perfusion.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralSellStrong SellSellBuy
Technical IndicatorsBuyStrong SellStrong SellStrong SellStrong Buy
SummaryNeutralStrong SellStrong SellStrong SellStrong Buy
  • Vote bullish thanks you
    0
    • uthr is coming up in my filter as a potential buy. what should be the right price to buypls share. I will share my analysis too
      0
      • uthr is coming up in my filter as a potential buy. what is the right price to enter? pls share. I will share my analysis too
        0
        • uthr is coming up in my filter as a potential buy. what is the right price to enter? pls share. I will share my analysis too
          0